| Date | Title | |
| 12/20/07 | MedImmune Expands Scientific and Engineering Leadership |  |
| 12/19/07 | Infinity and Medimmune Initiate Phase 2 Trial of IPI-504 to Assess the Hsp90 Inhibitor’s Potential Anti-Tumor Activity in Patients with Advanced Non-Small Cell Lung Cancer | |
| 12/10/07 | Micromet and MedImmune Present New Clinical Data for MT103 at the American Society of Hematology Annual Meeting Suggesting Potent Single-Agent Activity in Patients with Relapsed Mantle Cell and Follicular Lymphoma | |
| 12/07/07 | AstraZeneca Presents its Global Biologics Organisation, MedImmune, at 2007 Analyst and Investor R&D Day | |
| 11/29/07 | Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE® Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin’s Lymphoma Patients | |
| 11/26/07 | MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis | |
| 11/14/07 | The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma | |
| 11/13/07 | Infinity and MedImmune Initiate Phase 2 Clinical Trial of IPI-504, a Novel HSP90 Inhibitor, in Patients with Advanced Hormone-Refractory Prostate Cancer | |
| 11/08/07 | MedImmune Presents Data from Its Advancing Inflammatory Disease Portfolio at 71st Annual Meeting of The American College of Rheumatology | |
| 11/05/07 | MedImmune Announces Seven Key Promotions and New Hires | |
| 10/29/07 | PHOTO ADVISORY -- AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune | |
| 10/29/07 | AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune | |
| 10/29/07 | MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV | |
| 10/26/07 | MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition | |
| 10/25/07 | Infinity and MedImmune Present Preliminary Phase 1 Data Demonstrating Biological Activity of IPI-504, a Novel HSP90 Inhibitor, in Advanced Non-Small Cell Lung Cancer | |
| 10/24/07 | MedImmune Recognized by Local Volunteer Organization for Its Employees' Exceptional Commitment to Community Service within Montgomery County | |
| 10/23/07 | Infinity and MedImmune Announce Issuance of U.S. Patent for Proprietary Heat Shock Protein 90 Inhibitors | |
| 10/15/07 | MedImmune and Crucell Announce Collaboration to Develop New Antibodies for the Treatment and Prevention of Hospital-Acquired Bacterial Infection | |
| 10/09/07 | Data from MedImmune Infectious Disease Clinical Programs Presented at European Society for Paediatric Research Annual Meeting | |
| 10/04/07 | MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results | |
| 09/24/07 | MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production | |
| 09/19/07 | FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age | |
| 09/17/07 | Infinity and MedImmune Receive Orphan Drug Designation for IPI-504 for Treatment of Gastroinstestinal Stromal Tumors | |
| 09/07/07 | MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R) | |
| 08/23/07 | MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters | |
| 08/23/07 | MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study | |
| 08/23/07 | MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production | |
| 08/01/07 | MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma | |
| 07/23/07 | MedImmune Announces Interim Phase 1 Study Results for Potential Asthma Therapy | |
| 07/19/07 | MedImmune Advances Potential Treatment for Patients With Lupus | |
| 07/16/07 | RSV Drug Starts Phase Ia Clinical Trials | |
| 07/03/07 | MedImmune Begins Dosing Children Six Months to 24 Months of Age in Phase 1 Study of Vaccine to Help Prevent Two of the Most Common Viral Causes of Childhood Respiratory Illness | |
| 06/29/07 | New Study in Journal of Pediatrics Suggests Synagis(R) (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants | |
| 06/18/07 | MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 2013 | |
| 06/14/07 | Medimmune Is Awarded Contract By U.S. Department Of Health and Human Services to Retrofit Manufacturing Facilities For Production of Pandemic Influenza Vaccines | |
| 06/12/07 | MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM) | |
| 05/31/07 | Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO | |
| 05/25/07 | MedImmune Receives Correspondence From FDA Regarding FluMist(R) | |
| 05/24/07 | MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations | |
| 05/16/07 | FDA Advisory Committee Recommends Expanded Use of FluMist(R) | |
| 05/08/07 | Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings | |
| 05/08/07 | MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease | |
| 05/07/07 | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers | |
| 05/07/07 | MedImmune and Pediatric Infectious Diseases Society Present 2007 Career Development Award and Viral Respiratory Disease Fellowship | |
| 05/02/07 | MedImmune, Inc. Announces Convertibility of 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 2013 | |
| 05/02/07 | Pediatric Academic Societies' Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV | |
| 04/30/07 | MedImmune Reports Financial Results for 2007 First Quarter | |
| 04/30/07 | MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE® Molecule | |
| 04/23/07 | AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion | |
| 04/18/07 | MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases | |
| 04/18/07 | Micromet and MedImmune Present Data From Preclinical Study of New BiTE(R) Molecule Targeting CEA | |
| 04/12/07 | MedImmune Explores Strategic Alternatives | |
| 04/10/07 | Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR | |
| 04/09/07 | MedImmune Announces Preliminary Results for 2007 First Quarter | |
| 04/02/07 | MedImmune Promotes Three Leaders in Key Scientific & Medical Roles | |
| 04/02/07 | MedImmune Announces Addition of Robert H. Hotz To Board of Directors | |
| 03/29/07 | MedImmune Licenses Reverse Genetics Technology to sanofi pasteur for Use in Influenza Vaccine Production | |
| 03/23/07 | MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With Psoriasis | |
| 03/21/07 | Research Results on FluMist(R) Presented at National Association of Pediatric Nurse Practitioners Conference | |
| 03/16/07 | MedImmune Leases Human Genome Sciences Facility to Expand Cell Culture Influenza Vaccine Manufacturing Capabilities | |
| 03/12/07 | MedImmune to Present at the Tenth Annual Lehman Brothers Global Healthcare Conference | |
| 03/06/07 | MedImmune to Present at the Cowen & Co. 27th Annual Health Care Conference | |
| 02/20/07 | MedImmune Further Expands its Commercial Organization Expertise With Appointment of Two Additional Vice Presidents | |
| 02/14/07 | Study Published in The New England Journal of Medicine: 55 Percent Fewer Cases of Flu in Young Children Vaccinated With FluMist(R) Vs. Flu Shot | |
| 02/14/07 | Infinity and MedImmune Initiate Phase I/II Clinical Trial of IPI-504 for Patients With Non-Small Cell Lung Cancer | |
| 02/07/07 | MedImmune Reports Financial Results For 2006 | |
| 01/10/07 | MedImmune Announces District Court's Rejection of Sun Pharmaceutical's Motion to End Litigation Regarding Generic Amifostine | |
| 01/09/07 | MedImmune Issues Statement Regarding U.S. Supreme Court Decision | |
| 01/08/07 | FDA Approves MedImmune's Refrigerated Formulation of FluMist(R) | |
